瑞芬太尼
医学
麻醉
僵硬人综合征
罗库溴铵
麻醉剂
鞘内
罗库溴铵
异丙酚
谷氨酸脱羧酶
生物化学
酶
化学
作者
Hironobu Morita,Hirotaka Kinoshita,Masayo Kiyokawa,Tetsuya Kushikata,Kazuyoshi Hirota
出处
期刊:A&A practice
[Wolters Kluwer]
日期:2024-02-01
卷期号:18 (2): e01758-e01758
被引量:2
标识
DOI:10.1213/xaa.0000000000001758
摘要
Stiff-person syndrome (SPS) is a rare autoimmune disease characterized by fluctuating rigidity and stiffness of the axial muscles. There are no reports on the use of remimazolam in a patient with SPS. A 16-year-old Japanese woman with SPS was scheduled to undergo intrathecal baclofen pump exchange. General anesthesia was induced and maintained using remimazolam, remifentanil, and intermittent rocuronium bromide. No intraoperative mobility or significant autonomic symptoms were observed. Additionally, electroencephalographic signature showed sufficient anesthetic depth. The patient’s emergence from general anesthesia was uneventful. In conclusion, remimazolam could be considered an effective anesthetic drug for patients with SPS.
科研通智能强力驱动
Strongly Powered by AbleSci AI